References
- Zarate YA, Hopkin RJ. Fabry's disease. Lancet 2008;372(9647):1427–35.
- Spada M, Pagliardini S, Yasuda M, et al. High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet 2006;79(1):31–40.
- Mehta A, Ginsberg L. Natural history of the cerebrovascular complications of Fabry disease. Acta Paediatr Suppl 200594(447):24–7, 9–10.
- Salviati A, Burlina AP, Borsini W. Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy. Neurol Sci 2010;31(3):299–306.
- Sims K, Politei J, Banikazemi M, Lee P. Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry. Stroke 2009;40(3):788–94.
- Putaala J, Metso AJ, Metso TM, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke 2009;40(4):1195–203.
- Ferro JM, Massaro AR, Mas JL. Aetiological diagnosis of ischaemic stroke in young adults. Lancet Neurol 2010;9(11):1085–96.
- Eng CM, Guffon N, Wilcox WR, et al. Safety and efficacy of recombinant human alpha-galactosidase A–replacement therapy in Fabry's disease. N Engl J Med 2001;345(1):9–16.
- Schiffmann R. Fabry disease. Pharmacol Ther 2009;122(1):65–77.
- Shi Q, Chen J, Pongmoragot J, et al. Prevalence of Fabry disease in stroke patients–a systematic review and meta-analysis. J Stroke Cerebrovasc Dis 2014;23(5):985–92.
- Adams HJ, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 1993;24(1):35–41.
- Kes VB, Cesarik M, Zavoreo I, et al. Guidelines for diagnosis, therapy and follow up of Anderson-Fabry disease. Acta Clin Croat 2013;52(3):395–405.
- Wu G, Pang S, Feng X, et al. Genetic analysis of lysosomal alpha-galactosidase A gene in sporadic Parkinson's disease. Neurosci Lett 2011;500(1):31–5.
- Rolfs A, Bottcher T, Zschiesche M, et al. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 2005;366(9499):1794–6.
- Brouns R, Sheorajpanday R, Braxel E, et al. Middelheim Fabry study (MiFaS): a retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic stroke. Clin Neurol Neurosurg 2007;109(6):479–84.
- Brouns R, Thijs V, Eyskens F, et al. Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease. Stroke. 2010;41(5):863–8.
- Marquardt L, Baker R, Segal H, et al. Fabry disease in unselected patients with TIA or stroke: population-based study. Eur J Neurol 2012;19(11):1427–32.
- Rolfs A, Fazekas F, Grittner U, et al. Acute cerebrovascular disease in the young: the stroke in young Fabry patients study. Stroke 2013;44(2):340–9.
- De Brabander I, Yperzeele L, Ceuterick-De GC, et al. Phenotypical characterization of alpha-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young. Clin Neurol Neurosurg 2013;115(7):1088–93.
- Baptista MV, Ferreira S, Pinho-E-Melo T, et al. Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE study–screening genetic conditions in Portuguese young stroke patients. Stroke 2010;41(3):431–6.
- Oliveira JP, Ferreira S, Barcelo J, Gaspar P, Carvalho F, Sa MM, et al. Effect of single-nucleotide polymorphisms of the 5' untranslated region of the human alpha-galactosidase gene on enzyme activity, and their frequencies in Portuguese caucasians. J Inherit Metab Dis 2008;31(Suppl 2):S247–53.
- Oliveira JP, Ferreira S, Reguenga C, et al. The g.1170C>T polymorphism of the 5' untranslated region of the human alpha-galactosidase gene is associated with decreased enzyme expression–evidence from a family study. J Inherit Metab Dis 2008;31(Suppl 2):S405–13.
- Nakamura K, Sekijima Y, Nakamura K, et al. p.E66Q mutation in the GLA gene is associated with a high risk of cerebral small-vessel occlusion in elderly Japanese males. Eur J Neurol 2014;21(1):49–56.
- Togawa T, Tsukimura T, Kodama T, et al. Fabry disease: biochemical, pathological and structural studies of the alpha-galactosidase A with E66Q amino acid substitution. Mol Genet Metab 2012;105(4):615–20.